✦ LIBER ✦

Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly

✍ Scribed by Philippe Chanson; Françoise Borson-Chazot; Jean-Marc Kuhn; Joëlle Blumberg; Pascal Maisonobe; Brigitte Delemer; the Lanreotide Acromegaly Study Group

Book ID: 108704087
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 207 KB
Volume: 69
Category: Article
ISSN: 0300-0664
DOI: 10.1111/j.1365-2265.2008.03208.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

One-year follow-up of patients with acro

One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel®

✍ Ph. Caron; M. Bex; D. R. Cullen; U. Feldt-Rasmussen; A. M. Pico Alfonso; S. Pynk 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB

Efficacy of lanreotide Autogel® administ

Efficacy of lanreotide Autogel® administered every 4–8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: a phase III trial

✍ T. Lucas; R. Astorga; ; the Spanish–Portuguese Multicentre Autogel Study Group o 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

A 12-month randomized crossover study on

A 12-month randomized crossover study on the effects of Lanreotide Autogel and Octreotide long-acting repeatable on GH and IGF-l in patients with acromegaly

✍ Magdalene Andries; Dorte Glintborg; Annette Kvistborg; Claus Hagen; Marianne And 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Rapid and sustained reduction of serum g

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel®therapy: a randomized, placebo-controlled, multicenter study with a 52

✍ Shlomo Melmed; David Cook; Jochen Schopohl; Miklos I. Goth; Karen S. L. Lam; Jos 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 395 KB